Strategic collaboration for novel antibody development At the 2026 J.P. Morgan Healthcare Conference, Shanghai Henlius Biotech announced an exclusive global... Read more
Tag: #Global Trends
Nutritional solutions supporting new-generation weight loss medication users
The synergy of real-world experience and scientific evidence The Atkins brand has announced a partnership with reality TV star Heather... Read more
Exelixis targets top 5 ranking in U.S. solid tumor oncology market
Despite currently operating with a single-drug portfolio, Exelixis has outlined a strategic expansion plan aiming to become one of the... Read more
Phase 3 clinical trial outcomes for Epkinly in lymphoma treatment
Latest findings from the Epcore DLBCL-1 clinical trial for Epkinly (epcoritamab), a bispecific antibody developed through the partnership between AbbVie... Read more
Infant formula recalled in Singapore following toxin detection
The Singapore Food Agency (SFA) has ordered a recall of specific batches of infant formula from brands Nestlé and Dumex.... Read more
Vedanta Biosciences executes major workforce reduction to fund lead microbiome program
In a strategic consolidation of resources, Vedanta Biosciences has significantly downsized its headcount to prioritize its primary live bacterial consortium... Read more
QPS integrates Oracle Argus to strengthen clinical trial safety management
QPS Holdings, a global contract research organization (CRO), has implemented the Oracle Argus pharmacovigilance system to enhance its safety case... Read more
Apiject to establish North Carolina facility for essential injectable medicines
Apiject Holdings Inc. has secured a 30,000-square-foot pharmaceutical site in Apex, North Carolina, to bolster domestic production of critical healthcare... Read more
Cytotheryx secures $60M Series A to advance regenerative liver therapies
Cytotheryx, a preclinical-stage cell therapy firm originating from the Mayo Clinic, has closed a $60 million Series A funding round.... Read more









